{"schema_version":"1","generated_at":"2026-11-22T15:23:59.021Z","data_as_of":null,"url":"https://www.findmykol.com/kol/brian-patson","json_url":"https://www.findmykol.com/kol/brian-patson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"brian-patson","name":"Brian Patson","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Lehigh Valley Health Network","institution_url":"https://www.findmykol.com/institution/lehigh-valley-health-network","city":"Allentown","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Brian Patson is an Oncology physician affiliated with Lehigh Valley Health Network. OpenAlex indexes 13 publications with 5,570 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":13,"cited_by_count":5570,"h_index":8,"latest_activity_year":2020,"source":"works"},"prescribing":{"data_year":2022,"areas_total":7,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":36.6,"classes_total":5,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":12.8,"drugs":[{"name":"Morphine Sulfate Er","share_pct":60.4},{"name":"Oxycodone Hcl","share_pct":39.6}],"max_beneficiaries":null},{"class":"Phenothiazine","setting":"prescribed","share_pct":9.4,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":26}]},{"area":"Sensory organs","share_pct":24.3,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":24.3,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":29}]},{"area":"Cancer & immunology","share_pct":13,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":8.9,"drugs":[{"name":"Imbruvica","share_pct":54.1},{"name":"Xalkori","share_pct":45.9}],"max_beneficiaries":null},{"class":"Antimetabolite","setting":"prescribed","share_pct":4.1,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":13,"shown":5,"withheld":8,"matched_by":"OpenAlex author record","recent":[{"title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial","year":2020,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(20)32531-9","status":"verified"},{"title":"Durvalumab with Concurrent Definitive Radiation Therapy (DART) for Locally-Advanced Non-Small Cell Lung Cancer - A Phase II Study","year":2020,"journal":"International Journal of Radiation Oncology*Biology*Physics","source_url":"https://doi.org/10.1016/j.ijrobp.2020.07.584","status":"verified"},{"title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","year":2019,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(19)32591-7","status":"verified"},{"title":"Identifying Baseline Characteristics for Consideration of Prophylactic Feeding Tube Placement in Persons Undergoing Chemoradiotherapy for Head and Neck Cancer: A Retrospective Chart Review","year":2019,"status":"verified"},{"title":"Effectiveness of a thoracic multidisciplinary clinic in the treatment of stage III non-small-cell lung cancer","year":2016,"journal":"Journal of Multidisciplinary Healthcare","source_url":"https://doi.org/10.2147/jmdh.s98345","status":"verified"}],"source":"works"},"similar":[{"name":"Timothy Friel","slug":"timothy-friel","institution":"Lehigh Valley Health Network","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/timothy-friel","json_url":"https://www.findmykol.com/kol/timothy-friel/profile.json"},{"name":"Armaan Dhaliwal","slug":"armaan-dhaliwal","institution":"Lehigh Valley Health Network","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/armaan-dhaliwal","json_url":"https://www.findmykol.com/kol/armaan-dhaliwal/profile.json"},{"name":"Negar Moheb","slug":"negar-moheb","institution":"Lehigh Valley Health Network","specialty":"Neurology","url":"https://www.findmykol.com/kol/negar-moheb","json_url":"https://www.findmykol.com/kol/negar-moheb/profile.json"},{"name":"Sharon Maynard","slug":"sharon-maynard","institution":"Lehigh Valley Health Network","specialty":"Nephrology","url":"https://www.findmykol.com/kol/sharon-maynard","json_url":"https://www.findmykol.com/kol/sharon-maynard/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":8}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}